Question

Difficulty: Very hardDepressive Disorders

A 64-year-old man is evaluated in the outpatient clinic for a severe major depressive episode 3 months after suffering an acute anterior myocardial infarction. He is currently hemodynamically stable and compliant with his post-myocardial infarction medical regimen, which includes dual antiplatelet therapy. He reports pervasive anhedonia, early morning awakening, profound fatigue, and feelings of worthlessness. Over the subsequent 18 months, despite extensive medical management, his depressive disorder proves highly resistant to standard therapies, eventually precipitating a severe clinical deterioration characterized by extreme food refusal, profound dehydration, and catatonic posturing requiring emergent hospitalization.

Arrange the following psychiatric management steps in the most appropriate, evidence-based chronological sequence for this patient, from initial evaluation in the outpatient clinic to the management of his final acute decompensation.

  1. 1Perform a comprehensive safety assessment and meticulously screen for a history of manic or hypomanic episodes.
  2. 2Initiate monotherapy with sertraline, ensuring careful monitoring for gastrointestinal bleeding risk.
  3. 3Augment the regimen with an atypical antipsychotic (e.g., aripiprazole) or cross-taper to an alternative first-line antidepressant class following failure of an 8-week optimized trial.
  4. 4Admit for inpatient psychiatric stabilization and administer urgent electroconvulsive therapy (ECT).

Answer

The correct sequence is: 1) Screen for a history of mania, 2) Initiate sertraline monotherapy, 3) Augment or switch antidepressants after initial monotherapy failure, 4) Administer urgent ECT for catatonia and life-threatening inanition.
The management of major depressive disorder follows a distinct, stepped-care algorithm. Initial evaluation must strictly rule out bipolar disorder before the commencement of antidepressant therapy to avoid manic switching. Once unipolar depression is confirmed, a first-line agent is initiated; in a post-myocardial infarction patient, sertraline is the safest choice due to its lack of significant cardiovascular or QTc-prolonging effects. If the patient fails to respond after an adequate 6-8 week trial at maximum tolerated doses, the regimen is escalated either by switching to another first-line agent or adding an augmenting medication like an atypical antipsychotic. Finally, if the patient develops life-threatening complications such as severe inanition, food refusal, or catatonia, rapid definitive intervention is required, making electroconvulsive therapy (ECT) the absolute treatment of choice regardless of prior medication failures.

Step-by-Step Solution

1
Rule out bipolar disorder.
Patient is confirmed to have unipolar major depressive disorder.
Antidepressant monotherapy in an undiagnosed bipolar patient can trigger an acute manic episode.
2
Select and initiate a safe first-line antidepressant based on comorbidities.
Sertraline is chosen and titrated to a therapeutic dose for an 8-week trial.
The patient's recent myocardial infarction dictates the use of sertraline, which has the safest post-MI cardiovascular profile compared to other SSRIs (like citalopram) or TCAs.
3
Escalate therapy due to treatment resistance.
The regimen is augmented with an atypical antipsychotic or transitioned to a different antidepressant class.
Standard stepped-care algorithms require changing the mechanism of action or augmenting when an adequate trial of initial monotherapy fails.
4
Implement definitive emergent somatic therapy.
The patient is hospitalized and receives ECT.
The progression to catatonia and severe food refusal is a life-threatening psychiatric emergency that requires the rapid response rate uniquely provided by ECT.

Key Concept

Stepped-care escalation of Major Depressive Disorder (MDD) in patients with cardiovascular comorbidities, culminating in emergent ECT for catatonia.
Rate this question